Cancer researchers question antitrust arguments against Illu

U.S. and European antitrust enforcers want to unwind gene sequencing leader Illumina Inc's purchase of cancer test company Grail, saying the two would stifle competition in a critical area of... | December 16, 2022

Related Keywords

Portland , Oregon , United States , Brussels , Bruxelles Capitale , Belgium , Texas , Chicago , Illinois , Washington , Foo Yun Chee , Diane Bartz , Sadik Esener , Julie Steenhuysen , Deena Beasley , Pacific Biosciences , Los Angeles , Chris Sanders , Ernest Hawk , Caroline Humer , Sciences Corp , Guardant Health , University Of Texas Md Anderson Cancer Center , Cancer Early Detection Advanced Research Center , Eu Commission , Knight Cancer Institute In Portland , Delfi Diagnostics Inc , Reuters , Ultima Genomics Inc , Us Federal Trade Commission , Thermo Fisher Scientific Inc , Rutgers Law School , Cancer Institute , Trade Commission , Michael Carrier , Rutgers Law , Diagnostics Inc , Exact Sciences Corporation Stock Exchange , News , Information , Press Release , End , European , Antitrust , Enforcers , Want , O , Nwind , Gene , Sequencing , Leader , Illumina , Purchase , F , Dancer , Pest , Company , Saying , The , Two , Would , Stifle , Competition , N , Critical , Rea Exas Us30063p1057 ,